Not every presentation of emphysematous pyelonephritis calls for the same response. The extent of gas involvement and the degree of retained renal function are central to clinical decision-making — and determine which intervention pathway is appropriate.

Clinical scenario

This protocol addresses the specific sub-group of patients with localised areas of gas in whom functioning kidney tissue is still present — the scenario where a targeted, organ-sparing drainage approach is supported by the evidence.

Treatment approach (partial)

Management centres on image-guided percutaneous drainage. The complete protocol defines the precise patient selection criteria, technical requirements, and tube management parameters that govern this approach.

Full regimen details, procedural specifications, and duration criteria are in the structured protocol below.

Treatment goals

Success is confirmed radiologically. A follow-up CT scan demonstrating complete disappearance of gas and full resolution of inflammation marks the endpoint — a process that may require up to 12 weeks.

References

DOI: 10.1038/nrurol.2009.51

Definitive management is by percutaneous drainage, except when there is extensive diffuse gas with renal destruction; in this case, a nephrectomy is advised.

Percutaneous drainage is the most appropriate management strategy for most patients.

Percutaneous drainage should be performed on patients who have localized areas of gas where there is still functioning kidney tissue.

The procedure is optimally performed under CT guidance.

The tubes used should be of good caliber (at least 14 Fr); with this size of tube, irrigation is not necessary.

The drainage tubes should stay in place until a follow-up CT scan shows disappearance of the gas and resolution of inflammation, which might take up to 12 weeks.

View source ↗

Emphysematous Pyelonephritis: Treatment When Localized Gas Is Present with Preserved Kidney Function

References